You just read:

Lilly to Present New Data for Taltz® (ixekizumab) in Psoriasis and Psoriatic Arthritis at the American Academy of Dermatology (AAD) Annual Meeting

News provided by

Eli Lilly and Company

28 Feb, 2017, 09:00 ET